The suite will give patients access to a premium pain management service and cutting-edge treatments, all on one floor.
We know that navigating pain that spans multiple specialties can feel overwhelming and frustrating. That’s why we’ve expanded the Welbeck London Treatment Suite — a premium, consultant-led spinal health and pain management service, all on one floor.
With 6 new individual patient pods to ensure comfortable admissions and recoveries, and an additional consultation room enabled for ultrasounds and ultrasound-guided injections, the now 5,000 square feet centre is purpose-built to support pain-relieving procedures via sedation and local anaesthetic.
“The Treatment Suite at Welbeck has been designed to deliver high-quality, discreet interventional care in a safe and comfortable environment,” said Dr Alex Kumar, Consultant in Spinal Medicine & Pain Management, and Dr Ben Thomas, Consultant in Spine & Pain Medicine. “Personal, private space has been prioritised with ensuite rooms available for patients to both prepare for their procedure and to recover after it. The footprint has been designed to allow easy access to the intervention room and immediate access to nursing staff if assistance is needed, protecting dignity and ensuring a smooth and efficient patient experience.”
In the Treatment Suite, Welbeck consultants will employ their world-class expertise to treat patients with a range of conditions, including acute and chronic pain, sciatica, headaches and migraines, neuropathic pain, cancer-related pain, fibromyalgia, post-surgical pain, and neuropathy.
Here’s how we’ll continue to deliver best-in-class, seamless care for our patients:
Our comprehensive multidisciplinary team approach brings together leading pain consultants, spinal specialists, neurosurgeons, and expert radiologists to provide patients with unrivalled pain management and coordinated, holistic care.
“Pain can be debilitating, affecting every element of a patient's life from sleep to work and at home,” said Dr Kumar and Dr Thomas. “Rapid access to highly experienced specialists supported by modern imaging techniques alongside the new dedicated Treatment Suite allows pain management interventions to be delivered early in a patient's journey, restoring function, enabling rehabilitation, and reducing the risks of the pain becoming chronic.”
From same-day appointments to urgent referrals, daily clinics ensure faster access and timely interventions so patients can avoid frustrating and unnecessary delays in receiving assessment and treatment.
Welbeck is one of only a small number of centres in Europe offering the innovative Intracept® (BVN ablation) procedure, an advanced treatment for vertebrogenic chronic lower back pain. Advanced treatments such as lidocaine and ketamine infusions are also available, as are ultrasound-guided pain injections, pulsed radiofrequency, medical acupuncture, and neuromodulation, including spinal cord stimulation devices.
Our consultants are motivated by clinical excellence and work to personalise every patient’s treatment plan to their unique needs and goals — something Welbeck’s unparalleled range of treatment options allows them to achieve.
The newly expanded Treatment Suite is our way of strengthening our commitment to making healthcare even more convenient and accessible for our patients.
If you’re experiencing symptoms, are looking for treatment, or need a second opinion, click here to make an appointment with a Welbeck London specialist today.
Allergic rhinitis (or hay fever) is one of the most common allergic conditions affecting millions of people across the globe. New research shows a link between gut health and the onset and management of allergic responses, including hay fever.
What happens when you bring together the hosts of The Good, The Bad & The Rugby podcast for a full body MOT? Read on for a behind-the-scenes look at their tests, results and everything in between.
Dr Malik says “alcohol is a potent driver for atrial fibrillation (AF) and cutting back reduces the risk of it coming back. This article in the NEJM provides more evidence for this”.